Clinical Trials Logo

Heart Disease clinical trials

View clinical trials related to Heart Disease.

Filter by:

NCT ID: NCT01365741 Completed - Clinical trials for Ischemic Heart Disease

Time to Thrombocytic Inhibition After Supine and Upright Ingestion of Efient

Start date: February 2011
Phase: N/A
Study type: Interventional

The purpose of the study is to clarify wether body posture during ingestion of 60mg Efient, a thrombocytic inhibitor, has influence on the time to thrombocytic inhibition. The study aims to mimic the treatment Danish patients receive when admitted to the hospital with a ST-elevation myocardial infarction since these patients are refereed to acute Percutaneous Coronary Intervention (PCI) necessitating fast and efficient thrombocytic inhibition. Current guidelines recommend the administration of Efient right before the PCI procedure, while the patient is lying down, either in the ambulance or in the operating room. We, the investigators, believe that this is suboptimal for the patient, since any sort of prolonged inhibition time will possibly worsen the patients prognosis and make the patient more prone to later clotting issues. Our hypothesis is that by making the patients ingest the tablets in a 90 degrees upright position and making them sit up for 2 minutes after ingestion, the effect of the pills will commence faster than if taken in a supine position. This will possibly lead to faster inhibition of the thrombocytes, which we believe will lead to a lower incidence of clotting issues during and after the procedure.

NCT ID: NCT01335880 Completed - Obesity Clinical Trials

Helping People to Exercise Regularly

Start date: April 2011
Phase: N/A
Study type: Interventional

This study tests two different incentive mechanisms to induce members of a particular urban senior center to attend more exercise classes. Coupons for future use are given to participants who attend an exercise class and will be redeemable within either a one week or three month time period, depending on which experimental group the participant is assigned to. Frequency of exercise class attendance at the end of 2 months will be the primary outcome.

NCT ID: NCT01331187 Completed - Dyspnea Clinical Trials

Influence of Routinely Adding Ultrasound Screening in Medical Department

Start date: April 1, 2011
Phase: N/A
Study type: Interventional

Ultrasound (US) is widely used as a diagnostic tool in a hospital setting. In a medical department, diagnosis like heart failure or most kinds of heart diseases, hypervolemia, hypovolemia, pleural effusion, pericardial effusion, ascites, diseases in the gall bladder/bile tract, urine tract and venous thrombosis are common. US is the key diagnostic tool in these diagnosis, and on early diagnosis is crucial with respect to the patients well-being and inpatients workflow. 1. The aim is to study the clinical use of pocket-size US as a screening diagnostic tool in an medical department with respect to inpatients workflow and diagnostics. Method: Patients admitted (in certain preset periods) to Department of medicine will be randomized to routinely adding an ultrasound examination with pocket-size device by residents on call. Time to definitive diagnosis, time to definitive treatment and time to discard will be recorded. US findings will be validated against standard echocardiography, or standard US/CT/MRI performed at the Radiological department.

NCT ID: NCT01325480 Terminated - Heart Failure Clinical Trials

High Septal Pacing for Cardiac Resynchronization Therapy

HISTORY
Start date: August 2011
Phase: Phase 0
Study type: Observational

The purpose of this acute study is to perform a preliminary investigation of high septal right ventricular pacing in the vicinity of the His bundle region as an alternate or adjunctive means for cardiac resynchronization in patients with heart failure and wide QRS.

NCT ID: NCT01321476 Withdrawn - Heart Disease Clinical Trials

Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis

Carotid
Start date: n/a
Phase: N/A
Study type: Observational

This study will use excess tissue from endoscopic or surgical procedures to examine the elements of plaque that are found in the carotid walls of patients who have a type of heart and blood vessel disease called atherosclerosis. Tissue will be collected from patients undergoing carotid procedures as well as patients undergoing liver and/or intestinal biopsies. This lab study will examine the different types of proteins that play a role in developing heart plaque.

NCT ID: NCT01281397 Terminated - Clinical trials for Coronary Artery Disease

Bleeding Prediction in Patients Following Cardiac Surgery Using Whole Blood Aggregometry and Thromboelastometry

Start date: August 2009
Phase: N/A
Study type: Observational

Use of whole blood impedance aggregometry and rotational thromboelastometry can reveal useful data about platelet function and viscoelastic properties of blood clot in patients undergoing cardiac surgery. The purpose of this study is to clarify whether it is possible to predict patients on excessive risk of perioperative bleeding using whole blood impedance aggregometry and rotational thromoelastometry. Antiplatelet therapy is the cornerstone in treatment of patients with coronary artery disease. Another research goal is to determine the degree of response to antiplatelet therapy before and after surgery and to investigate whether patients by level of response to antiplatelet therapy before surgery have a higher risk of perioperative bleeding.

NCT ID: NCT01231815 Recruiting - Heart Disease Clinical Trials

Coronary Flow Reserve Evaluation in PET and in MRI Scanner in Heart Transplanted Patients : Comparison With Multi-detectors Scanner

RECOPE
Start date: November 2010
Phase: N/A
Study type: Interventional

Heart transplantation is the ultimate therapeutic option in patients with end-stage heart failure. Since advances in the treatment of acute rejection has increased early transplant survival, cardiac allograft vasculopathy (CAV) is the main factor limiting long-term survival. The prevalence of angiographically proven CAV is high, documented in 40-50% of transplant recipients 5 years after transplantation. Therefore, annual coronary angiography remains widely used to monitor transplanted patients, although pathologic studies and intravascular ultrasonography have demonstrated that coronary angiography underestimates the severity of CAV. Perfusion SPECT may underestimate allograft vasculopathy in case of diffuse coronary lesions. In this setting, the assessment of coronary reserve by means of Positron Emission Tomography (PET) and perfusion cardiac magnetic resonance imaging (CMR) have not been investigated.

NCT ID: NCT01228032 Completed - Diabetes Clinical Trials

The Health Outcomes Management and Evaluation (HOME) Study

HOME
Start date: April 2010
Phase: Phase 3
Study type: Interventional

There is an urgent need to develop practical, sustainable approaches to improving medical care for persons treated in community mental health settings. This study will test a novel approach for improving mental health consumers based on a partnership model between a Community Mental Health Center and a Community Health Center. When this study is completed, it will provide a model for a medical home for persons with severe mental illness that is clinically robust, and organizationally and financially sustainable

NCT ID: NCT01218802 Completed - HIV Infections Clinical Trials

Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks

Start date: February 2011
Phase: Phase 2
Study type: Interventional

The hypothesis of this study is that 96 weeks of Rosuvastatin will be safe and effective in decreasing cardiovascular risk and bone loss in the HIV+ population.

NCT ID: NCT01196533 Completed - Diabetes Clinical Trials

A Comparative Clinical Trial of the TensorTip, a Novel Non Invasive Device for Measurement Blood Parameters

Start date: August 2010
Phase: N/A
Study type: Interventional

1. Aim: The aim of the clinical trial is to study the accuracy of the TensorTip device compared with registered (FDA-approved) invasive and non-invasive devices. 2. Hypothesis: Human physiological biomarkers may be measured from the color distribution of the internal or external (skin) tissue. The technology of the TensorTip finger-mounted device is based on the color distribution of the peripheral blood tissue, which enables the measurement of certain biomarkers and vital signs under consideration.